Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Short-term corticosteroid therapy for chronic active hepatitis B.

T Laskus1, J Cianciara, T Loch

  • 1Department of Hepatology, Institute of Infectious and Parasitic Diseases, Warsaw, Poland.

Digestion
|January 1, 1990
PubMed
Summary

Short-term prednisone treatment for chronic active hepatitis B showed promise, clearing hepatitis B e antigen (HBeAg) and DNA polymerase in most patients. However, one patient experienced severe liver failure, highlighting potential risks.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Nodular tumour of the Vas deferens with epithelial structures].

Der Pathologe·2021
Same author

[Digital transformation in urology-opportunity, risk or necessity?]

Der Urologe. Ausg. A·2021
Same author

[Artificial intelligence : What do urologists need to know?]

Der Urologe. Ausg. A·2020
Same author

Corrigendum to: Hepatitis C virus (HCV) infection of peripheral blood mononuclear cells in patients with type II cryoglobulinemia. Hum Immunol. 2013;74(12):1559-62.

Human immunology·2017
Same author

Histiocytic necrotising lymphadenitis in mediastinum mimicking thymoma or lymphoma - case presentation and literature review of Kikuchi Fujimoto disease.

Polish journal of pathology : official journal of the Polish Society of Pathologists·2016
Same author

[Not Available].

Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]·2016

Area of Science:

  • Hepatology
  • Virology
  • Immunology

Background:

  • Chronic active hepatitis B is a significant global health concern.
  • Hepatitis B e antigen (HBeAg) and DNA polymerase are key viral markers.
  • Effective treatment strategies for chronic active hepatitis B are needed.

Purpose of the Study:

  • To evaluate the efficacy and safety of short-term prednisone treatment in chronic active hepatitis B patients.
  • To assess the impact of prednisone on HBeAg and DNA polymerase levels.
  • To compare treatment outcomes with a matched control group.

Main Methods:

  • Seventeen patients with chronic active hepatitis B received 4 weeks of prednisone.
  • Patients were initially HBeAg and DNA polymerase positive.

Related Experiment Videos

  • A 1-year follow-up period was conducted, with a matched untreated control group.

    • Main Results:

    • 11 of 17 patients cleared HBeAg, and 10 became DNA polymerase negative.
    • Control group showed minimal clearance of HBeAg and DNA polymerase.
    • One patient experienced reactivation, prolonged liver disease, and died of liver failure.

    Conclusions:

    • Short-term corticosteroid therapy may benefit some chronic active hepatitis B patients.
    • Prednisone treatment carries a risk of severe adverse events, including liver failure.
    • Careful patient selection and monitoring are crucial for this therapeutic approach.